Particle Data Platform

Why we aren’t studying it

24:5625:30 · 34s

A blunt assessment: no profits, no studies. Casperson argues women’s neuroprotection is undervalued, blocking the big trials needed on generic testosterone.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.